Bone Biologics Corporation (BBLG) vs CDT Equity Inc. (CDT)
A side-by-side comparison of Bone Biologics Corporation and CDT Equity Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BBLG
Bone Biologics Corporation
$0.47HealthcareDelayed quote: Oct 6, 2026, 2:12 PM EDT
CDT
CDT Equity Inc.
$0.86HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT
Total return — BBLG vs CDT
growth of $100 · dividends reinvested · last 3yBBLG -98.5% (-75.4%/yr)CDT -100.0% (-99.8%/yr)BBLG compounded faster over this window
Log scale — wide-divergence pair
BBLG CDT
BBLG vs CDT: by the numbers
- •BBLG is the larger company ($857758 vs $664676 market cap).
- •CDT is profitable (6.30% net margin) while BBLG runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | BBLG | CDT |
|---|---|---|
| P/S ratio | N/A | 0.00 |
| P/B ratio | 0.22 | 0.00 |
| EV / EBITDA | N/A | 4.13 |
Profitability
| Metric | BBLG | CDT |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 6.30% |
| ROE | -73.66% | 6.58% |
| ROIC | -78.01% | 4.47% |
Frequently asked
- Is BBLG or CDT more profitable?
- CDT runs the higher net margin — BBLG at 0.00% versus CDT at 6.30%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.